Navigation Links
Asian spice could reduce breast cancer risk in women exposed to hormone replacement therapy
Date:7/13/2009

COLUMBIA, Mo. Previous studies have found that postmenopausal women who have taken a combined estrogen and progestin hormone replacement therapy have increased their risk of developing progestin-accelerated breast tumors. Now, University of Missouri researchers have found that curcumin, a popular Indian spice derived from the turmeric root, could reduce the cancer risk for women after exposure to hormone replacement therapy.

"Approximately 6 million women in the United States use hormone replacement therapy to treat the symptoms of menopause," said Salman Hyder, the Zalk Endowed Professorship in Tumor Angiogenesis and professor of biomedical sciences in the College of Veterinary Medicine and the Dalton Cardiovascular Research Center. "This exposure to progestin will predispose a large number of post-menopausal women to future development of breast cancer. The results of our study show that women could potentially take curcumin to protect themselves from developing progestin-accelerated tumors."

In the study, researchers found that curcumin delayed the first appearance, decreased incidence and reduced multiplicity of progestin-accelerated tumors in an animal model. Curcumin also prevented the appearance of gross morphological abnormalities in the mammary glands. In previous studies, MU researchers showed that progestin accelerated the development of certain tumors by increasing production of a molecule called VEGF that helps supply blood to the tumor. By blocking the production of VEGF, researchers could potentially reduce the proliferation of breast cancer cells. Curcumin inhibits progestin-induced VEGF secretion from breast cancer cells, Hyder said.

"Curcumin and other potential anti-angiogenic compounds should be tested further as dietary chemopreventive agents in women already exposed to hormone replacement therapy containing estrogen and progestin in an effort to decrease or delay the risk of breast cancer associated with combined hormone replacement therapy," Hyder said.


'/>"/>

Contact: Kelsey Jackson
JacksonKN@missouri.edu
573-882-8353
University of Missouri-Columbia
Source:Eurekalert

Related medicine news :

1. Conventional prognostic factors fail to explain better prostate cancer survival in most Asian men
2. West Clinic Continues Expansion Into Asian Market With Opening of Shanghai Cancer Center
3. FalconStor Software Inc. Founders Make Multi-Million Dollar Donation to North Shore-LIJ Health System for Asian Community Health Center in Flushing
4. Emerging therapies with a focus on Asian populations mark the AACR Centennial Conference
5. Mannatech Hosts Australasian Convention
6. Non-Caucasians at higher risk for severe metastatic breast cancer pain
7. Chinas biotech industry: An Asian dragon is growing
8. Access Licenses MuGard(TM) to RHEI Pharmaceuticals, a Leading Specialty Pharmaceutical Company for Distribution in China and Certain Other Southeast Asian Countries
9. Asian women at risk for arterial defect
10. Carringtons DelSite Drug Delivery Technology Granted Patent From Eurasian Patent Office
11. African Americans Show Facial Aging in Eyes Earlier Than Caucasians
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... ... December 06, 2016 , ... Healthcare ... federal healthcare regulations at the 7th annual Health IT Leadership Summit, to be ... acting administrator for the Centers for Medicare & Medicaid Services (CMS), will be ...
(Date:12/6/2016)... PA (PRWEB) , ... December 06, 2016 , ... ... identification and characterization laboratories, is now offering HIAC particle counting and sizing services ... immediately. , Gateway Analytical instituted the new service as a response to the ...
(Date:12/6/2016)... ... 06, 2016 , ... 'Tis the season for family, festivity, food and fun! ... the season when eating healthy, staying active, and taking medication and doing daily foot ... do. , "Shopping trips, parties and family gatherings can take their toll on ...
(Date:12/6/2016)... ... 2016 , ... The OSHA Training Center at Chabot-Las ... headquartered in Northern California, has announced the addition of a Public Sector Safety ... to public sector employees. , “The primary goal of the Public Sector Safety ...
(Date:12/5/2016)... TX (PRWEB) , ... December 05, 2016 , ... ... for Facial Plastic Surgery, is excited to announce the arrival of the newest ... fractional laser, with the ability to use tunable non-ablative and ablative wavelengths for ...
Breaking Medicine News(10 mins):
(Date:12/6/2016)... 2016 /PRNewswire/ - InMed Pharmaceuticals, Inc. ("InMed") (CSE: ... R&D program in the use of cannabinoids for ... In June, 2015 InMed initiated its COPD program ... targets and potential active compounds that can be ... in vitro assays using human lung fibroblasts (HFL-1 ...
(Date:12/5/2016)...  Balloon catheter is an innovative medical device that ... femoral artery in the leg or sometimes into the ... vessels. These products are generally used to prevent blood ... lipid substances in the blood vessel. In terms of ... expand at a CAGR of 3.8% during the forecast ...
(Date:12/5/2016)... , Dec. 5, 2016 Spain Glaucoma ... GlobalData,s new report, "Spain Glaucoma Surgery Devices Market Outlook ... Glaucoma Surgery Devices market. The report provides value, in ... prices (USD) within market segements - Canaloplasty Micro Catheters ... company shares and distribution shares data for each of ...
Breaking Medicine Technology: